Topics

Articles

Industry is still scrambling to handle clerical errors of DSCSA transactions.

FDA Finalizes the Definitions of 'Suspect and Illegitimate' Pharma Products 

Event—taking place in Indianapolis—places supply chain education at the forefront. 

HDA’s 2023 Distribution Management Conference Dives into DSCSA Specifics and More

The Pulse online service will provide free resources to enable pharmacy to meet drug traceability rules.

NABP Hopes to Fill a Key Gap in DSCSA Compliance: Local Pharmacies

With the help of traceability, new feature prioritizes efficiency and safety, from production to patient.

Fresenius Kabi Introduces Unit-of-Use 2D Barcodes 

Meanwhile, PDG issues more DSCSA guidance on data interoperability.

HDA Seeks to Limit FDA Enforcement Discretion of DSCSA Come November, Raising the Burden on Some Manufacturers

Marie Flanagan is Director, Offering Management, Vigilance Detect at 

If there’s anything we learned from the pandemic, it’s the critical need to analyze patient outcome data in real time to stay informed on the safety and efficacy of treatments in the real world

The Challenges of Safety Risk Detection: The Automation Solution

Features an ATP solution to allow for efficiency

Systech Partners with Spherity on Facilitating DSCSA Compliance

The clock is ticking on a massive effort to bring interoperable, electronic tracking of pharma shipments in the US

Countdown to 2023 DSCSA Compliance

A recommended checklist for manufacturers as they enlist distributor and 3PL support—and the important questions they should be asking themselves  

The Key Steps Ahead of DSCSA D-Day

Pressure is mounting ahead of looming unit-level serialization required by the Drug Supply Chain Security Act—necessitating a wide scope of collaboration on compliance